Epilepsy drugs: getting it right the first time

Lancet Neurology

Volumn 6, Issue 6, 2007, Pages 476-478

  Faught, Edward ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LAMOTRIGINE; OXCARBAZEPINE; TOPIRAMATE; VALPROIC ACID;

BONE DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG CHOICE; DRUG COST; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG POTENTIATION; DRUG TOLERABILITY; FOCAL EPILEPSY; GENERALIZED EPILEPSY; GRAND MAL SEIZURE; HEALTH CARE COST; HUMAN; LETTER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEIZURE; UNSPECIFIED SIDE EFFECT;

ANTICONVULSANTS; EPILEPSY; HUMANS;

EID: 34248395146     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(07)70115-1     Document Type: Letter

References (8)

1. Epilepsy (adults)-newer drugs (2004), National Institute for Clinical Excellence, London. http://www.nice.org.uk/page.aspx?o=109115 Technology appraisal guidance TA76, National Institute for Clinical Excellence
2. Marson A., Al-Kharousi A., Alwaidh M., et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 369 (2007) 1000-1015
3. Marson A., Al-Kharousi A., Alwaidh M., et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalized and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 369 (2007) 1016-1026
4. Brodie M., Richens A., Yuen A., and for the UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 345 (1995) 476-479
5. Rowan A., Ramsay R., Collins J., et al., for the VA Cooperative Study 428 Group. New onset geriatric epilepsy: a randomised study of gabapentin, lamotrigine, and topiramate. Neurology 64 (2005) 1868-1873
6. Nicolson A., Appleton R., Chadwick D., and Smith D. The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies. J Neuro Neurosurg Psychiatry 75 (2004) 75-79
7. Meador K., Baker G., Finnell R., et al. In utero antiepileptic drug exposure: fetal death and malformations. Neurology 67 (2006) 407-412
8. Sheth R. Bone health in epilepsy. Lancet Neurol 9 (2004) 516